Officials will discuss Xi’s offer of cooperation with India to develop COVID-19 vaccine: China


PTI, Nov 18, 2020, 5:46 PM IST

Beijing: Officials of China and India will discuss the modalities of cooperation to develop COVID-19 vaccine which was proposed by President Xi Jinping during the BRICS summit, the Chinese Foreign Ministry said on Wednesday.

In his speech at the 12th BRICS summit, Xi said on Tuesday that the Chinese companies are working with their Russian and Brazilian partners on phase three clinical trials for vaccines.

“We are prepared to have cooperation with South Africa and India as well,” he said addressing the virtual summit, hosted by Russian President Vladimir Putin and attended by Prime Minister Narendra Modi, Brazilian President Jair Bolsonaro and South African President Cyril Ramaphosa.

“China has joined the COVAX facility and will actively consider providing vaccines to the BRICS countries where there is a need,” Xi said.

Asked what kind of cooperation China is seeking with India on the development of vaccines, Chinese Foreign Ministry spokesman Zhao Lijian told a media briefing here that “China will work to ensure the affordability and accessibility of vaccines for developing countries.”

“We will continue to cooperate with all countries to promote our vaccine cooperation so as to achieve victory over the virus at an early date. As for details, competent authorities will have more discussions and communications with their counterparts on this issue,” he said.

The World Health Organisation (WHO) has said nine candidate vaccines, including two from China, are currently being evaluated for inclusion in the COVAX Facility.

The COVAX is co-led by Gavi, an international vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO. Its aim is to accelerate the development and manufacture of vaccines.

China has roped in more than a dozen countries including Brazil to conduct the final phase trials of Chinese-made experimental COVID-19 vaccines and even started vaccinating thousands of its emergency workers, according to official media reports here.

Yang Sheng, Deputy Director of the National Medical Products Administration’s drug registration bureau, said recently that four China-developed COVID-19 vaccines have begun the final stage of human trials overseas after obtaining approval from foreign authorities.

China has been focusing on developing five types of vaccines, and each method has at least one entering clinical trials. In total, 11 vaccine candidates are in different stages of testing, Yang said.

So far the coronavirus, which originated in the Chinese city of Wuhan, has infected more than 54 million people around the world and killed over 1.3 million others.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

For ‘Bhoomi Putra’ Kharge, prestigious LS poll battle in Karnataka

Ahead of Lok Sabha polls, I-T department slaps Congress with Rs 1700 cr, demand notice: Report

Kejriwal’s wife launches WhatsApp campaign to garner support for AAP leader

BJP’s Brijesh Chowta to file nomination papers on April 4; discloses assets

What court said as it extended Kejriwal’s ED custody till April 1

ED wants AAP’s LS poll strategy details from Kejriwal’s phone: Atishi

Mukhtar Ansari was subjected to slow poisoning in jail: Son

Related Articles More

Cranes arriving to start removing wreckage from deadly Baltimore bridge collapse

Trump will attend the wake of a slain NYPD officer as he goes after Biden over crime

UN secy-general appoints top NDMA official as special representative for disaster risk reduction

Jaishankar meets Malaysian counterpart, discusses ‘multifaceted’ bilateral ties

Baltimore bridge collapse: Entire crew of container ship ‘Indian’

MUST WATCH

Theft in a rented house @ Dandeli

World Sparrow Day

Sri Vishwaprasanna tirtha swamiji

How To Grow Healthy Red Amaranth leaves

Hotel Soorya


Latest Additions

Row over candidate intensifies as Cong scrambles to finalise pick in faction-ridden Kolar unit

FPIs make remarkable comeback; infuse Rs 2 lakh cr in equities in FY24

UP court orders judicial probe into Mukhtar Ansari’s death

PM cautions ‘significant risk of misuse’ of AI and other powerful tech in unskilled, untrained hands

Lok Sabha polls 2024: District poll panels fix varied menu, ceiling for poll expenditure

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.